R&D Keeping the pandemic at bay with needle-free vaccine deliver... COVID-19 is still circulating and there are fears that further spikes in cases are to be expected in the coming months.
News Agios shares slide as it abandons sickle cell candidate Agios Pharma has said it will halt clinical development of tebapivat, a PK activator that had reached phase 2 testing in sickle cell disease.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
